Article
Document
Anualidad
Academic Article
Information Content Entity
Continuant
Entity
Generically Dependent Continuant
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up
RDF description of Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up - http://research.umh.es/vivo/pub/articulo/218558